Meyka Pro banner
Nexalin Technology, Inc.

Nexalin Technology, Inc. Fundamental Analysis (NASDAQ: NXL)

NXL●NASDAQ
HealthcareMedical - Devices
$7.66
$3.31(75.98%)
U.S. Market is Open · 12:54

Nexalin Technology, Inc. Fundamental Analysis (NASDAQ: NXL)

Nexalin Technology, Inc. (NASDAQ: NXL) shows weak financial fundamentals with a PE ratio of -0.29, profit margin of -41.39%, and ROE of -2.78%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position33.32%
PEG Ratio-0.01

Areas of Concern

ROE-2.78%
Operating Margin-42.03%
We analyze NXL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -4212.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-4212.2/100

We analyze NXL's fundamental strength across five key dimensions:

Efficiency Score

Weak

NXL struggles to generate sufficient returns from assets.

ROA > 10%
-2.99%

Valuation Score

Excellent

NXL trades at attractive valuation levels.

PE < 25
-0.29
PEG Ratio < 2
-0.01

Growth Score

Weak

NXL faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

NXL maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
1.25

Profitability Score

Weak

NXL struggles to sustain strong margins.

ROE > 15%
-278.25%
Net Margin ≥ 15%
-41.39%
Positive Free Cash Flow
No

Key Financial Metrics

Is NXL Expensive or Cheap?

P/E Ratio

NXL trades at -0.29 times earnings. This suggests potential undervaluation.

-0.29

PEG Ratio

When adjusting for growth, NXL's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Nexalin Technology, Inc. at 1.96 times its book value. This may indicate undervaluation.

1.96

EV/EBITDA

Enterprise value stands at -0.46 times EBITDA. This is generally considered low.

-0.46

How Well Does NXL Make Money?

Net Profit Margin

For every $100 in sales, Nexalin Technology, Inc. keeps $-41.39 as profit after all expenses.

-41.39%

Operating Margin

Core operations generate -42.03 in profit for every $100 in revenue, before interest and taxes.

-42.03%

ROE

Management delivers $-2.78 in profit for every $100 of shareholder equity.

-2.78%

ROA

Nexalin Technology, Inc. generates $-2.99 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.99%

Following the Money - Real Cash Generation

Operating Cash Flow

Nexalin Technology, Inc. generates limited operating cash flow of $-6.38M, signaling weaker underlying cash strength.

$-6.38M

Free Cash Flow

Nexalin Technology, Inc. generates weak or negative free cash flow of $-6.47M, restricting financial flexibility.

$-6.47M

FCF Per Share

Each share generates $-8.81 in free cash annually.

$-8.81

FCF Yield

NXL converts -2.00% of its market value into free cash.

-2.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.29

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.96

vs 25 benchmark

P/S Ratio

Price to sales ratio

14.29

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.25

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-2.78

vs 25 benchmark

ROA

Return on assets percentage

-2.99

vs 25 benchmark

ROCE

Return on capital employed

-6.01

vs 25 benchmark

How NXL Stacks Against Its Sector Peers

MetricNXL ValueSector AveragePerformance
P/E Ratio-0.2930.40 Better (Cheaper)
ROE-278.25%582.00% Weak
Net Margin-4139.38%31088.00% Weak
Debt/Equity0.000.53 Strong (Low Leverage)
Current Ratio1.255.91 Neutral
ROA-299.21%5.00% Weak

NXL outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Nexalin Technology, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ